MediSwipe Inc. Announces New Members to Its Advisory Board

Company Expands Advisory Board With Healthcare Professionals in Preparation of National Launch of MediSwipe Biometric Data Management Software to Medicinal States


LOS ANGELES, May 1, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. (www.MediSwipe.com) (OTCBB:MWIP), a patient security solutions and data management company for the medicinal marijuana and health care industry, today announced  the addition of two members to its Strategic Advisory Board. These two esteemed individuals will provide expertise in the areas of digital healthcare management, best-of-class business practices and advancements in biometric monitoring technology. The newest members of the Advisory Board are Mr. Kevin Deitch and Mr. Timothy Winn. Mr. Deitch and Mr. Winn join Dr. James Canton bringing the total advisory board members of MediSwipe to three.

MediSwipe's Management Team is extremely enthused about the several key additions. "Over the past several months, we have sought out the key players in the healthcare sector that would add tremendous potential and credentials to our Advisory Board. Each member contributes unique insight to our approach. While the members validate many of our concepts, their individual talents and contributions have rapidly refined our strategy," stated B. Michael Friedman, CEO of MediSwipe. "With the experience and added expertise of our new Advisory Board, MediSwipe now has access to the highest level thought leaders in the healthcare and digital information management sectors," further added Friedman.

Kevin E. Deitch is the Executive Vice President and Founder of Digital Records, Inc., a privately-held Florida-based corporation that specializes in cloud based software development and document scanning services. In addition to providing unmatched scanning services, the Company is the sole distributor of Beltora DMS, an Electronic Content Management and Document Capture Software Solution, to the United States and Europe

Mr. Deitch has received 3 degrees from the University of Florida, including a 'Master of Business Administration' in 2002, in which he graduated first in his class. Mr. Deitch's medical scanning experience includes White Wilson Medical Medical Centers (150,000 Patients), Water's Edge Dermatology (70,000 Patient Records), Western Communities Family Practice (80,000 Patient Records), Cardiology Associates of the Palm Beach's (50,000 Patient Records), University of Miami, Sylvester (Document Scanning Software for 50 employees; 1st EMR), and ARAN Eye Associates (64,000 Patient Records).

Major Fortune 500 Past Accounts include: LabCorp, Fedex, Office Depot, Unisys, Pepsi Co., Coca Cola, and AMD.

Previous University Projects and Relationships: Stanford University, Harvard University, Massachusetts Institute of Technology, Princeton University, Michigan State University, Colorado State University, University of Miami, and Iowa State University

Mr. Winn comes to MediSwipe as a Director of Technology of Digital Records Inc. and Image Access, Inc., a startup imaging software and solutions company.

While with Image Access, Mr. Winn played an integral role from both a design and execution standpoint on projects including The Library of Congress, American Express, Ancestry.com, Pepsi, Office Depot, the 2000 Mexican census and the design and development of core components of the Stanford University Robotic Scanning Lab. (http://library.stanford.edu/depts/dlss/bookscanning/).

About MediSwipe Inc.

MediSwipe Inc. (www.MediSwipe.com) provides innovative patient solutions for electronically processing transactions within the healthcare industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and Accounts Receivable Financing.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.


            

Contact Data